Ethics in Publishing
The Journal adheres to the principles set forth in the Helsinki Declaration and holds that all reported research involving "Human beings" conducted in accordance with such principles.
All papers reporting experiments using animals must include a statement in the MATERIAL AND METHODS section giving assurance that all animals have received human care in compliance with the Guide for the Care and Use of Laboratory Animals and indicating approval by the institutional ethical review board.
Plagiarism
Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical behavior and is unacceptable. Authors should submit original works and sources must be appropriately cited or quoted.
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check and subsequently reviewed for their suitability for publication in the Journal of Oncological Sciences. Manuscripts with high plagiarism, insufficient originality, serious scientific or technical flaws are rejected.
Duplicate Submission
Authors should not submit the same manuscript or similar manuscript based on the same database, in the same or different languages, simultaneously to more than one journal.
Declaration of Interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. in the title page file or the manuscript file. If there are no interests to declare then please state this: 'Declarations of interest: none'. This summary statement will be ultimately published if the article is accepted. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission Declaration and Verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of Inclusive Language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').
Copyright
The Journal of Oncological Sciences is protected by copyright law. The Copyright Agreement Form should be signed and attached to submissions. As of April 2025, the journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND 4.0) International License. By signing this form, the authors agree that the article, if accepted for publication in the Journal of Oncological Sciences, will be licensed under a CC BY-NC-ND 4.0 license, which permits third parties to copy, distribute, or reuse the content in unadapted form only for non-commercial purposes, provided the author and original source are properly cited.
Authors hold both the scientific and ethical liability, as well as the copyright for the manuscripts. Commercial rights to the manuscripts are transferred to the Turkish Society of Medical Oncology if the article is accepted for publication.
The CC BY-NC-ND license includes the following elements:
BY – Credit must be given to the creator
NC – Only noncommercial uses of the work are permitted
ND – No derivatives or adaptations of the work are permitted
Role of the Funding Source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Author(s) and copyright owner(s) grant access to all users for the articles published in the Journal of Oncological Sciences as free of charge.
Open Access Policy is based on rules of Budapest Open Access Initiative (BOAI). By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
Licence Terms
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article
Submission
Our ONLINE ARTICLE system guides you stepwise through the process of entering your article details and uploading your files.
Editable files (e.g., Word ) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Free-of-Charge Publication
No fee is charged from the authors during the submission, evaluation and publication process. Journal practices, ethical rules, technical information and necessary forms are specified on the journal's web page.
The manuscripts must be submitted via the Manuscript Manager online article system, represented on the journal website.
How to Cite
The abbreviated name of the Journal of Oncological Sciences is "J Oncol Sci". Please use this abbreviation while citing a publication from the journal. An example of a cited article:
Nayir E, Cor S, Altintas ZM, et al. Comparative investigation of antitumoral effectiveness of Rho-kinase inhibitor Y-27632, pravastatin and atorvastatin in anaplastic thyroid cancer cell culture. J Oncol Sci.2017;3:62-65.
Peer Review
This journal operates a double-blind review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.
This journal uses a double-blind review, which means the identities of the authors are concealed from the reviewers, and vice versa.
Advertising Policy
Journal of Oncological Science (JOS) receives advertising support for its print and electronic editions and maintains editorial integrity through policies that define the Editorial/Advertiser relationship:
- Print and electronic advertising does not influence editorial decisions, and advertising is not an endorsement by the Publisher, Editor, or the Editorial Board.
- JOS reserves the right to refuse any advertising for any reason preserving the conditions consistent with the journal’s high standards of healthcare editorial.
- Editors have full and final authority for approving print and electronic advertisements and for enforcing the advertising policy.
- Print advertisements are interspersed throughout the journal but do not interrupt the flow articles. The journal website contains online banner advertising.
- To avoid implied endorsement by the Journal, the article, or the authors of the article; advertisements are not adjacent to articles addressing the product or its disease state.
- The Publisher reserves the right to print the word “Advertisement” on any advertisement where it may not be clear, so readers can distinguish readily between advertising and editorial. It is the responsibility of the advertiser and its agencies to adhere to appropriate legal requirements and regulations.
